How much is the Non-Small Cell Lung Cancer Drugs Market market?

The non-small cell lung cancer drugs market market size is estimated to grow at $$ 21061.2 mn in 2023. Read More

What is the growth rate of the Non-Small Cell Lung Cancer Drugs Market market?

The growth rate of the non-small cell lung cancer drugs market year-over-year is 10.87%. Read More

Which region held the largest market share in the Non-Small Cell Lung Cancer Drugs Market market?

North America is the region to held the largest market share with 38% growth. Read More

Who are the key players in the Non-Small Cell Lung Cancer Drugs Market market?

AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, BeiGene Ltd., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., DeuterOncology NV, Eli Lilly .... Read More

Which Segment has the largest market share in the Non-Small Cell Lung Cancer Drugs Market market?

Type is the segment that has the largest market share in the market. Read More

Non-Small Cell Lung Cancer Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, Canada, UK - Size and Forecast 2024-2028

Published: Jul 2024
Pages: 177
SKU: IRTNTR72354

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

2.2 Market characteristics
- Market characteristics analysis

2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition

3.2 Market segment analysis
- Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Non-Small Cell Lung Cancer Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Non-Small Cell Lung Cancer Drugs Market 2018 - 2022 ($ million)

4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)

4.3 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)

4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)

4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)

6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type

6.3 Adenocarcinoma - Market size and forecast 2023-2028
- Chart on Adenocarcinoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Adenocarcinoma - Market size and forecast 2023-2028 ($ million)
- Chart on Adenocarcinoma - Year-over-year growth 2023-2028 (%)
- Data Table on Adenocarcinoma - Year-over-year growth 2023-2028 (%)

6.4 Squamous cell carcinoma - Market size and forecast 2023-2028
- Chart on Squamous cell carcinoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Squamous cell carcinoma - Market size and forecast 2023-2028 ($ million)
- Chart on Squamous cell carcinoma - Year-over-year growth 2023-2028 (%)
- Data Table on Squamous cell carcinoma - Year-over-year growth 2023-2028 (%)

6.5 Large cell carcinoma - Market size and forecast 2023-2028
- Chart on Large cell carcinoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Large cell carcinoma - Market size and forecast 2023-2028 ($ million)
- Chart on Large cell carcinoma - Year-over-year growth 2023-2028 (%)
- Data Table on Large cell carcinoma - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Product

7.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)

7.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product

7.3 Biologics - Market size and forecast 2023-2028
- Chart on Biologics - Market size and forecast 2023-2028 ($ million)
- Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
- Chart on Biologics - Year-over-year growth 2023-2028 (%)
- Data Table on Biologics - Year-over-year growth 2023-2028 (%)

7.4 Small molecule targeted therapy - Market size and forecast 2023-2028
- Chart on Small molecule targeted therapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Small molecule targeted therapy - Market size and forecast 2023-2028 ($ million)
- Chart on Small molecule targeted therapy - Year-over-year growth 2023-2028 (%)
- Data Table on Small molecule targeted therapy - Year-over-year growth 2023-2028 (%)

7.5 Chemotherapy - Market size and forecast 2023-2028
- Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
- Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
- Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview

11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

11.3 Landscape disruption
- Overview on factors of disruption

11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered

12.2 Market positioning of companies
- Matrix on companies position and classification

12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings

12.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings

12.5 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings

12.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings

12.7 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus

12.8 BeiGene Ltd.
- BeiGene Ltd. - Overview
- BeiGene Ltd. - Business segments
- BeiGene Ltd. - Key offerings
- BeiGene Ltd. - Segment focus

12.9 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings

12.10 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings

12.11 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings

12.12 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus

12.13 Innovent Biologics Inc.
- Innovent Biologics Inc. - Overview
- Innovent Biologics Inc. - Product / Service
- Innovent Biologics Inc. - Key offerings

12.14 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus

12.15 Ono Pharmaceutical Co. Ltd.
- Ono Pharmaceutical Co. Ltd. - Overview
- Ono Pharmaceutical Co. Ltd. - Product / Service
- Ono Pharmaceutical Co. Ltd. - Key offerings

12.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings

12.17 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix